Engineering of strong, pliable tissues
AssigneeChildren's Medical Center Corporation
InventorsJoseph P. Vacanti, Christopher K. Breuer, Beverly E. Chaignaud, Toshiraru Shin'oka
Life of this patent
Estimating the term…
Loading patent…
AssigneeChildren's Medical Center Corporation
InventorsJoseph P. Vacanti, Christopher K. Breuer, Beverly E. Chaignaud, Toshiraru Shin'oka
Estimating the term…
It has been discovered that improved yields of engineered tissue following implantation, and engineered tissue having enhanced mechanical strength and flexibility or pliability, can be obtained by implantation, preferably subcutaneously, of a fibrous polymeric matrix for a period of time sufficient to obtain ingrowth of fibrous tissue and/or blood vessels, which is the removed for subsequent implantation at the site where the implant is desired. The matrix is optionally seeded prior to the first implantation, after ingrowth of the fibrous tissue, or at the time of reimplantation. The time required for fibrous ingrowth typically ranges from days to weeks. The method is particularly useful in making valves and tubular structures, especially heart valves and blood vessels.
A cell-matrix structure comprising
A tissue-engineered heart valve formed of a porous polymeric matrix seeded with dissociated endothelial and fibroblast cells, wherein the cells form extracellular matrix following implantation into a human or animal recipient, and wherein the extracellular matrix is shaped to form a heart valve.
Dependencies are inferred from the claim text.